Financial Deals Industry Tracker: Pharmaceuticals and Healthcare (analysis of monthly deal activity, along with the trend for the last six months for merger and acquisition (M&A), private equity, venture financing, private placement, initial public offeri

This report contains extensive qualitative and quantitative analysis of monthly deal activity (including strategic alliances) in the biotechnology, healthcare services, medical devices, and pharmaceuticals sectors across global markets, with a specific focus on key emerging markets. It offers insights into deal activity, deal rationale, and valuation trends.

Report Highlights
• M&A transactions recorded a decline of 31.4% in value terms, although the pharmaceutical sector witnessed a few big ticket acquisitions. The biotechnology segment dominated M&A activity in May, driven by the significant interest in the oncology and vaccine markets, which is likely to continue.
• The home healthcare segment is likely to experience more M&A activity, as companies look to expand their presence; private equity players remain interested in other services. On-going consolidation in the generic drug markets and emerging economies dominated the deal activity in the pharmaceutical segment.
• Venture capitalists invested over $651 million in 52 companies, a decrease of 37.4% in value terms as compared to the last six month average. The pharmaceutical and healthcare sector recorded 11 public offerings, an increase of 22.2% on a month-on-month basis, indicating improved capital market conditions.
[Cerrar las informaciones del articulo de mercado]

1. Introduction
a. About Financial Deals
b. About this report

2. Mergers and acquisitions (including private equity deals)
a. Monthly roundup
b. Volume and value analysis by sector
c. Volume analysis by geography
i. Global regions (North America, Europe, Asia Pacific, and Rest of World)
ii. Emerging markets (BRIC, Middle East, Eastern Europe, Latin America, and Africa)
d. Value analysis by geography
i. Global regions (North America, Europe, Asia Pacific, and Rest of World)
ii. Emerging markets (BRIC, Middle East, Eastern Europe, Latin America, and Africa)
e. Trend analysis by deal size
f. Trend analysis by deal rationale and deal sub-category
g. Advisory ranking M&A (trailing six months) – financial and legal
h. Private equity firm ranking

3. Public offering
a. Monthly roundup
b. Volume and value analysis by geography
c. Trend analysis by deal size

4. Private placement
a. Monthly roundup
b. Volume and value analysis by geography
c. Trend analysis by deal size

5. Alliance / Partnership deals monthly roundup

6. Valuation trend: comparison across key sectors

7. Advisory ranking for all deals (trailing six months) – financial and legal

8. Appendix
a. Definition
b. Disclaimer
[Cerrar la tabla de contenidos]